Cytek Biosciences updates bylaws to add universal proxy rules for director elections

• Cytek Biosciences adopted amended and restated bylaws on Sept. 23, 2026, tightening rules for stockholder proposals and director nominations.
• Changes expand required disclosures, representations, and ownership commitments by proponents through the record date and meeting date.
• Universal proxy requirements under SEC Rule 14a-19 were added, increasing procedural demands for contested director elections.
• Chairperson authority was broadened to disregard non-compliant nominations or proposals, including at special meetings with added advance-notice procedures.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cytek Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-407330), on September 29, 2026, and is solely responsible for the information contained therein.